AIM There are limited population-based data on global development and adaptive behaviour in children with early-onset epilepsy. The aims of this study were: (1) to identify the prevalence of deficits in global development and adaptive behaviour experienced by children with early-onset epilepsy; (2) to identify factors associated with such deficits; and (3) to compare the relationship between measures of neurodevelopment in the group with epilepsy to a group without epilepsy who had other neurological or neurodevelopmental difficulties.
INTERPRETATION Children with early-onset epilepsy frequently have difficulties with global development and adaptive behaviour. The higher correlations between neurodevelopmental measures in children with epilepsy suggest that the profile in children with epilepsy is different. This may have significant implications for both neuropathology and interventions.
Early-onset epilepsy is associated with frequent epileptic seizures 1 and a high frequency of developmental and epileptic encephalopathies. 2 The associated neurodevelopmental and behavioural difficulties often have a greater impact on quality of life than the seizures. 3, 4 There is, however, a lack of population-based data on the prevalence of impairments in global development and adaptive behaviour in early-onset epilepsy as well as factors associated with such deficits. One previous population-based study 5 focused on cognition in children aged 3 to 6 years while another focused on global cognition in children of all ages including children under 5 years of age. 6 One previous study included a measure of adaptive behaviour in children under 3 years of age. 7 There is also a paucity of data on whether neurodevelopmental profiles in children with epilepsy are similar to children without epilepsy but with other neurodevelopmental or neurological conditions. A previous study of the relationship between cognitive measures in new-onset childhood epilepsy suggested a higher degree of correlation between cognitive domains in epilepsy compared with typically developing comparison individuals. 8 Knowledge of neurodevelopmental profiles in epilepsy is important for understanding the impact of epilepsy on child development. It may also have implications for intervention and prognosis, and facilitate a better understanding of the biological underpinnings of the impairments.
The aim of the Sussex Early Epilepsy and Neurobehaviour study was to identify, on a population basis, the prevalence of deficits in global development and adaptive behaviour experienced by children with early-onset epilepsy. An additional aim was to identify factors associated with such deficits. A final aim was to compare the relationship between measures of neurodevelopment (i.e. global development, adaptive behaviour, autism, and sleep) in the group with epilepsy with a group of age, sex, and developmentally-matched comparison individuals who had other neurological or neurodevelopmental difficulties without epilepsy.
METHOD Recruitment
Children born between 2008 and 2014 with epilepsy (a history of two or more unprovoked seizures >24h apart) and who were residing in the RH10 to RH14 postal districts in the south of England between 30th September 2014 and 29th February 2016 were eligible. Children needed to be at least 1 year of age during the study period to be included. The prevalence of lifetime (a history of two or more unprovoked epileptic seizures) epilepsy in the study area was calculated by using the 2011 UK census population data of 1-to 7-year-olds (19 393) provided by the UK Office of National Statistics (study area population 217 006).
Recruitment of children with epilepsy
Eligible children with epilepsy were identified via a link paediatrician (community paediatrician with a special interest in epilepsy). All paediatricians, neurophysiologists, and epilepsy nurses in the study area were asked to inform the link paediatrician of all current and new diagnoses of epilepsy within the study period.
The parents/guardians of eligible children were approached by the researchers and asked to complete an interest form if they wished to find out about the study. All parents who returned a form were met in their home. At this informed consent meeting, the study was described in detail and parents were asked for written consent for entry of their child into the study. Anonymized information was obtained on non-participants with epilepsy (n=5), including data on sex, age at median point in study, school placement (specialized or mainstream), diagnosis of autism spectrum disorder, or the presence of cerebral palsy.
Recruitment of children with neurological or neurodevelopmental difficulties
Once a child with epilepsy was enrolled in the study, the parents of children with similar attributes (age, sex, and estimated developmental level) without epilepsy attending the same clinics in the study area were approached by collaborating paediatricians. The children needed to have been referred for a neurological or neurodevelopmental concern and were judged by the research paediatrician to have neurological and/or neurodevelopmental symptoms which would require ongoing support.
Developmental level was estimated on the basis of school/preschool placement (special or mainstream) or previous psychological/developmental assessment or clinician judgement.
Psychological assessment
Eligible children in both groups underwent psychological assessment, including measures of global development, adaptive behaviour, parent-reported sleep, and symptoms of autism in their homes, between 1st November 2014 and 30th April 2016.
Global development was assessed using the Griffiths Mental Development Scales (GMDS) 9 or the Griffiths Mental Development Scales, Extended Revised (GMDS-ER). 10 Both are measures of global development and are used for children under 2 years and 2 to 8 years respectively. For low-functioning children 2 years or older, the GMDS can be used to estimate developmental level. Additionally, some children may span both measures. The GMDS-ER provides z-scores and it is also possible to calculate an overall developmental quotient on both instruments using the formula mental age/chronological age. The GMDS consists of five subscales: locomotor, personal-social, language, hand-eye coordination, and performance. The GMDS-ER contains the same five subscales plus an additional subscale on practical reasoning.
Adaptive behaviour was assessed using the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) 11 interview form administered with the child's primary caregiver. The VABS-II assesses the child's daily living skills in four domains and 11 subdomains: communication (receptive, expressive, and written subdomains), daily living skills (personal, domestic, and community subdomains), socialization (interpersonal relationships, play and leisure time, and coping skills subdomains) and motor (gross and fine motor skills subdomains). A total adaptive behaviour composite score reflecting overall functioning was also computed.
Parents of children in both groups also completed a measure of paediatric sleep (Child Sleep Habits Questionnaire) 12, 13 and a screening measure for autism spectrum disorder (Modified Checklist for Autism in Toddlers).
14 Clinical information on all children was extracted from medical records using a standardized pro forma including data on current antiepileptic drugs (number of current medications), seizures, and investigations (magnetic resonance imaging, electroencephalography). Clinical, electroencephalography, and neuroimaging data for the children with epilepsy were reviewed by two paediatric epileptologists to independently classify seizures and epilepsy syndromes as proposed by the Task Force of the International League Against Epilepsy in 2010. 15 When the assessors disagreed on the classification, conflicts were resolved by a third rater. The designation of primary What this paper adds
• Children with early-onset epilepsy are at significant risk of intellectual disability.
• Developmental impairment is associated with use of polytherapy but not with any seizure parameters.
• Developmental profiles in young children with epilepsy differ from other conditions.
referral concern of the children with neurological or neurodevelopmental difficulties was based on data extracted on the standardized proforma. Primary referral concerns were classified as 'global development', 'social communication only', or 'motor only'. The primary referral concerns of the children with neurological or neurodevelopmental difficulties are shown in Appendix S1 (online supporting information). In total, 35 children had a concern about global development noted, seven had a motor concern without reference to developmental delay noted, and 15 had social communication difficulties noted (six of whom did not have developmental delay mentioned as a referral concern).
Deprivation 
Statistical analysis
All analyses were done with IBM SPSS version 24.0 (IBM SPSS Statistics, IBM Corporation, Armonk, NY, USA) except for the correlational analyses which were done in R (R Core Team, R Foundation for Statistical Computing, Vienna, Austria; https://www.R-project.org/). v 2 analyses (or where appropriate Fisher's exact test) were performed to compare the demographic characteristics of the participants and non-participants in the group with epilepsy. Comparisons between the epilepsy and matched groups were performed with t-tests (or MannWhitney U tests where data were not normally distributed) or v 2 /Fisher's exact test analyses. Performance on the GMDS/GMDS-ER total score and subscales and VABS-II domains and composite score were categorized as normal (<1SD below the mean), between 1SD and 2SD below mean, and more than 2SD below the mean with respect to the standardization sample.
Linear regression analyses were done to identify the factors associated with developmental quotient score on GMDS/GMDS-ER and composite score on the VABS-II in the epilepsy sample and then the total sample. In both samples the factors included as possible predictors were ethnicity (white vs non-white), sex (male vs female), child's age (in years), and deprivation. Epilepsy status (present or absent) was also included in the total sample so that a consideration of its role was possible after adjusting for the other variables. To consider the possible role of epilepsy factors in the group with epilepsy, the following factors were also included in regression analysis: age at onset of first seizure (in years), seizure frequency (monthly or more often vs less often), current treatment (one antiepileptic drug [ In the first instance, all independent variables were tested by linear regression. Multivariable analysis was done by backward regression, with all predictors entered into the model to identify factors independently associated with the outcome variables. The a level for univariable and multivariable analyses was p<0.05.
All subdomains/subtests (i.e. GMDS/GMDS-ER [6] , VABS-II [11] , Child Sleep Habits Questionnaire [8] , and MCHAT [1] ) (Appendix S2) were included in the correlation analysis. Correlation matrices were computed separately for epilepsy and the comparison group, and values are presented in tabular form and in the form of a correlation matrix heatmap.
Ethics approval
The study was approved by the Westminster Research Ethics Committee and registered with the collaborating hospital primary care organization: The Sussex Community NHS Trust.
RESULTS

Characteristics of the sample
During the study period 53 children with epilepsy were identified in the study area who met eligibility criteria, 48 of whom subsequently underwent psychological assessment (Fig. 1 ). There were no significant differences between the participants and non-participants with epilepsy on any of the available characteristics (Appendix S3, online supporting information). In the comparison group, 56 parents returned an interest form and 48 agreed to participate (Fig. 1) . The prevalence of epilepsy in the study area during the study period was 2.7 per 1000 (1 in 370, 95% CI 285-476).
The main characteristics of the children in the Sussex Early Epilepsy and Neurobehaviour study are shown in Table I . With respect to aetiology, 19 children with epilepsy were considered to have unknown or undetermined aetiology, 17 genetic/presumed genetic, and 12 structural/ metabolic. Regarding syndromes, 13 children were considered to have an electroclinical syndrome, 13 a structural/ metabolic syndrome, 13 unknown causes, eight were unclassifiable, and one was categorized as having distinctive constellations.
There were no significant differences between the epilepsy and comparison group on any of the factors with the exception of ethnicity, where the group with epilepsy had proportionally more children who were non-white (p=0.008).
Performance on measures of development and adaptive behaviour
The performances of the children with epilepsy and the comparison group on the GMDS/GMDS-ER and VABS-II are shown in Table II. Seventy-one per cent of the group with epilepsy had a total score on the GMDS/GMDS-ER more than 2SD below the average while 56% had an adaptive behaviour composite score on the VABS-II below this level. The equivalent in the comparison group was 81% and 50%. The mean scores for the VABS-II and Griffiths (developmental quotient) total score and subscales/domains are shown in Appendix S4 (online supporting information). There was no significant difference between both groups on mean GMDS/GMDS-ER (p=0.523) or subdomains (see Appendix S3), mean VABS-II (p=0.628) or subdomains (see Appendix S4), mean Child Sleep Habits Questionnaire (p=0.075), or mean Modified Checklist for Autism in Toddlers (p=0.743).
Regression analysis
The regression analyses in the group with epilepsy for GMDS/GMDS-ER total score and VABS-II composite score are shown in Appendix S5 (online supporting information). Factors significantly associated with scores on both the GMDS/GMDS-ER and VABS-II on multivariable analysis were polytherapy and ethnicity. Children on polytherapy and children with non-white ethnicity were more likely to have lower scores. The results of regression in the total sample are shown in Appendix S5.
Correlations between psychological measures
The correlations between all subtests for both groups are shown in Appendices S6 and S7 (online supporting information). The neurodevelopmental measures were 
DISCUSSION
This is one of the first population-based studies of both global development and adaptive behaviour in children with early-onset epilepsy. The high rates of problems with global development and adaptive behaviour suggest that these children are at significant risk of meeting criteria for intellectual disability and thus are likely to need significant support throughout their lifespan. The correlation analysis indicates that the composition of neurodevelopment in children with early-onset epilepsy may differ from that in other groups. This warrants further exploration in terms of potential implications for intervention and for the pathophysiology of neurodevelopmental difficulties in childhood epilepsy.
In the current study 71% of children with epilepsy had a global developmental score, and 56% an adaptive behaviour composite score, more than 2SD below the average, highlighting the high risk of intellectual disability in this group. In a population-based cohort of 64 children (3y-6y 11mo) with epilepsy, Rantanen et al. 5 reported that 50% had an IQ score in the intellectually disabled range, while Berg et al. 6 reported that 33% of children with epilepsy under 5 years of age scored in the intellectually disabled range in a community-based study from the USA. More than half of the children with epilepsy had adaptive behaviour scores 2SD or more below the mean. There are limited population-based data on adaptive behaviour in childhood epilepsy. A study of 173 children with epilepsy before 3 years of age showed that the children had slightly impaired adaptive functioning scores at baseline and that scores declined significantly over three time points, 7 highlighting the potential for deficits to become more pronounced over time.
Polytherapy was the only epilepsy variable associated with lower scores on measures of global development and adaptive behaviour on multivariable analysis. The association between polytherapy and cognitive/developmental impairments has been described before in population-based studies focusing on global cognitive functioning in schoolaged children with epilepsy in the UK 16 and non-verbal intelligence in 6-to 12-year-olds in Norway. 17 It may reflect the need to try to treat drug-resistant seizures, which have a significant effect on cognition, or an underlying brain condition associated with both difficult-to-treat seizures and cognitive impairment. Previous studies have noted significant relationships between earlier age at seizure onset and poorer cognitive outcome. 5, 7, 16, 17 This was not found in the current study, possibly because most children had seizures at a young age.
In the current study, non-white ethnicity was associated with deficits in development and adaptive behaviour independent of deprivation. A previous study has shown that the risk of presenting with epilepsy before 2 years of age was highest for non-white groups. 18 Thus, it may be that the increased risk of developing epilepsy in young children of non-white ethnicity is also accompanied by an increased risk of significant neurodevelopmental impairment, but this finding needs replication in larger samples.
The higher correlations between subtests in the group with epilepsy is suggestive of poorer separation of function and a higher degree of interdependence between neurodevelopmental domains in this group. Our findings are in line with a previous study of the relationship between cognitive measures in new-onset childhood epilepsy, which suggested a higher degree of codependence between cognitive domains in epilepsy compared with typically developing individuals. 8 The current study thus indicates that neurodevelopment in children with epilepsy may also deviate from other children with neurological/neurodevelopmental difficulties. The underlying disease mechanisms in epilepsy might mean that the development of cognitive and behavioural functions may deviate from the development in children without epilepsy but with other neurological or neurodevelopmental concerns. The organization or network of neurodevelopment in children with epilepsy may be subject to changes with the development of the epileptic process, but also how children respond to antiepileptic drugs and other treatments. This may have implications for the design of educational, behavioural, and pharmacological interventions for affected children. One possible intervention that has shown efficacy in animal models of epilepsy is environmental enrichment, which might mean that children with epilepsy need very intensive early educational/behavioural intervention to optimize outcome. 19 A goal of such interventions may be to try to alter the underlying neurodevelopmental networks so that they become more optimal. 20 There are some limitations that need to be considered when interpreting the results of the current study. The sample size, although population-based with a high response rate, was relatively small. We used one method to identify children with epilepsy and thus may not have captured all cases. The instruments we used for sleep and autism are not normed for the full age range of children in this study. The comparison group was heterogeneous in terms of aetiology and this may have contributed to lower correlations across developmental domains. It will be useful to compare neurodevelopmental profiles in epilepsy with less heterogeneous groups to better understand whether the development of cognition and behaviour in epilepsy is significantly different. The comparison group Table II : Performance of children with epilepsy on GMDS/GMDS-ER and VABS-II
Epilepsy
Neurological or neurodevelopmental difficulties cannot be considered population-based and thus may not be representative of all children in the study area with neurological or neurodevelopmental difficulties, and we had no information on the non-responders in this group.
In conclusion, children with early-onset epilepsy have a high level of neurodevelopmental impairment. Comprehensive developmental assessment seems warranted for all these children. The observed difference between the epilepsy and comparison group in neurodevelopmental profile suggests that the neurobiological basis of the impairments might be different in epilepsy. This could have implications for possible educational, pharmacological, and behavioural interventions. Further prospective research in children with early-onset epilepsy is vital to track the course of neurodevelopment, and thus better understand the underlying mechanisms and course of the impairments.
